• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性抗凝蛋白活性降低对周围动脉疾病血管事件的影响。

Impact of reduced endogenous anti-coagulation protein activity on vascular events of peripheral arterial disease.

作者信息

Komai H, Juri M

机构信息

Department of Cardiovascular Surgery, Saiseikai Wakayama Hospital, Wakayama, Japan.

出版信息

Int Angiol. 2009 Apr;28(2):138-43.

PMID:19367244
Abstract

AIM

Aim of the study is to elucidate the prevalence and the prognosis of patients with peripheral arterial disease (PAD) who have reduced endogenous anti-coagulation protein activity.

METHODS

Ninety six patients with PAD were studied, including 45 patients with intermittent claudication and 51 with critical limb ischemia. Among them 65 patients underwent peripheral artery bypass grafting. Venous blood samples were obtained and plasma activity level of Protein C (PC), Protein S (PS), Plasminogen (PLG), Antithrombin (AT) were measured. Based on the patients' clinical database the prevalence and clinical relevance was studied.

RESULTS

In our PAD patients PC activity is reduced in 18.8%, PS activity is reduced in 16.7%, PLG activity was reduced in 15.6% and AT activity was reduced in 24.0%. The incidence of AT activity deficiency was significantly higher in patients with critical limb ischemia than patients with claudication (P<0.01). After revascularization, arterial event free rate of patients with PC or PS activity deficiency and those with PLG deficiency were significantly lower than those without during the mean follow-up period of 26+/-31 months. The incidence of thromboembolic episodes and leg amputation rate were significantly worse in patients with PC deficiency.

CONCLUSIONS

PAD patients with reduced endogenous anti-coagulation proteins show worse prognosis than those without. Surgeons must be aware of it to improve the outcome of arterial revascularization.

摘要

目的

本研究旨在阐明内源性抗凝蛋白活性降低的外周动脉疾病(PAD)患者的患病率及预后情况。

方法

对96例PAD患者进行研究,其中45例为间歇性跛行患者,51例为严重肢体缺血患者。65例患者接受了外周动脉搭桥手术。采集静脉血样本,检测蛋白C(PC)、蛋白S(PS)、纤溶酶原(PLG)、抗凝血酶(AT)的血浆活性水平。基于患者临床数据库研究患病率及临床相关性。

结果

在我们的PAD患者中,PC活性降低的占18.8%,PS活性降低的占16.7%,PLG活性降低的占15.6%,AT活性降低的占24.0%。严重肢体缺血患者的AT活性缺乏发生率显著高于间歇性跛行患者(P<0.01)。血运重建后,在平均26±31个月的随访期内,PC或PS活性缺乏患者以及PLG缺乏患者的无动脉事件发生率显著低于无这些缺乏情况的患者。PC缺乏患者的血栓栓塞发作发生率和截肢率显著更差。

结论

内源性抗凝蛋白降低的PAD患者预后比未降低的患者更差。外科医生必须意识到这一点,以改善动脉血运重建的结果。

相似文献

1
Impact of reduced endogenous anti-coagulation protein activity on vascular events of peripheral arterial disease.内源性抗凝蛋白活性降低对周围动脉疾病血管事件的影响。
Int Angiol. 2009 Apr;28(2):138-43.
2
Reduced Protein C Activity Might be Associated With Progression of Peripheral Arterial Disease.蛋白C活性降低可能与外周动脉疾病的进展有关。
Angiology. 2015 Jul;66(6):584-7. doi: 10.1177/0003319714544946. Epub 2014 Aug 12.
3
Particularities of peripheral arterial disease managed in vascular surgery in the French West Indies.法属西印度群岛血管外科治疗的外周动脉疾病的特点。
Arch Cardiovasc Dis. 2008 Jan;101(1):23-9. doi: 10.1016/s1875-2136(08)70251-1.
4
Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.人工血管膝上旁路重建术后旁路通畅和肢体挽救效果更佳的预测因素。
J Vasc Surg. 2016 Aug;64(2):380-388.e1. doi: 10.1016/j.jvs.2016.02.059.
5
Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.自体骨髓单个核细胞植入疗法在重度外周动脉疾病患者保肢手术中的应用。
J Vasc Surg. 2009 Dec;50(6):1378-90. doi: 10.1016/j.jvs.2009.07.113. Epub 2009 Oct 17.
6
Endogenous heparin activity is decreased in peripheral arterial occlusive disease.外周动脉闭塞性疾病中内源性肝素活性降低。
J Vasc Surg. 2008 May;47(5):1033-8. doi: 10.1016/j.jvs.2007.11.030. Epub 2008 Mar 6.
7
Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates.间歇性跛行患者的血运重建会导致更多的慢性肢体威胁性缺血和更高的截肢率。
J Vasc Surg. 2021 Sep;74(3):771-779. doi: 10.1016/j.jvs.2021.02.045. Epub 2021 Mar 26.
8
Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.外周动脉疾病患者血管再通治疗后主要动脉血栓栓塞性血管事件的发生率。
Ann Vasc Surg. 2021 Aug;75:217-226. doi: 10.1016/j.avsg.2021.02.025. Epub 2021 Apr 2.
9
An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety.一项对下肢血运重建十年经验的结果分析,包括肢体挽救率、住院时间和安全性。
J Vasc Surg. 2010 Apr;51(4):878-85, 885.e1. doi: 10.1016/j.jvs.2009.10.102. Epub 2010 Jan 4.
10
Anticoagulant proteins in a population of Mexican mestizo donors.墨西哥混血献血者群体中的抗凝血蛋白。
Ann Vasc Surg. 2015 Feb;29(2):222-6. doi: 10.1016/j.avsg.2014.09.023. Epub 2014 Nov 24.

引用本文的文献

1
Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis.外周动脉疾病患者心血管结局预测的血浆生物标志物:系统评价和荟萃分析。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2018-2032. doi: 10.1161/ATVBAHA.120.314774. Epub 2020 Jul 9.